Qsic Secures $25 Million USD in Series B Funding to Reinvent In-Store Audio For Retail Media

DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) — Qsic, the global intelligent in-store audio platform that elevates the in-store experience and drives incremental revenue, today announced that it closed a $25 million Series B funding round led by Hedosophia. Powering in-store audio and retail media for leading retailers and QSRs like 7-Eleven, Coles Express and McDonald's […]

Madison Realty Capital Originates $58 Million Financing to The Related Group and 13th Floor Investments for the Acquisition of Multifamily Property in Aventura, Florida

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on real estate private credit, today announced that it has originated a $58 million acquisition loan to The Related Group and 13th Floor Investments for the purchase of Arium Lincoln Pointe, a 285-unit multifamily waterfront

March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma

Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) — March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to MB-105, the company's

60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

(NASDAQ:SXTP),(NASDAQ:SXTPW), Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a presumptive diagnosis of chronic babesiosis in outpatient settings. Enrollment expected to commence Q3 2025. WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company

Introducing the CVS Health® app: Your go-to companion for health & wellness

A single app for consumers' whole health that provides convenience, savings and ease CVS Health® (NYSE: CVS) today announced the launch of the CVS Health app. New features of the app will bring together all CVS Health has to offer to consumers, helping make health care more accessible, affordable and convenient. https://mma.prnewswire.com/media/487051/CVS_Health_Logo.jpg “As a company,

New AI + Human CX Maturity Model Guides Enterprise Strategy for 2025

Glance's AI + Human Maturity Model™ gives CX leaders clarity in balanced CX for 2025 and beyond Glance, a leading provider of Guided Customer Experience (CX) solutions, published its AI + Human Maturity Model™ for Customer Experience, a resource for CX and product leaders seeking to harmonize artificial intelligence and human expertise in their customer

Welcome to the digital skills revolution: EIT Digital launches the (d)Academy

EIT Digital is proud to announce the launch of the (d)Academy, a cutting-edge digital skills platform developed to address the critical shortage of digital talent across Europe. Created in partnership with Abodoo, a leader in remote talent-matching, the (d)Academy is designed to tackle a challenge that affects individuals, businesses, and entire economies: over 75% of

RepRisk Business Conduct and ESG Risk Data Now Available to Bloomberg Customers

RepRisk's AI-powered business conduct and ESG risk data is now accessible on Bloomberg, further equipping the global financial industry with actionable insights on companies' business conduct risks and real performance Today,RepRisk, the world's most respected data technology company for business conduct and ESG risk, announced that its data is now accessible on the Bloomberg Terminal1,

Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses

Oxidative stress drives aging and is a key factor in diseases like Alzheimer’s, Age-related Macular Degeneration (AMD), cardiovascular diseases, cancer, and diabetes. It also plays a critical role in the progression of viral infections, such as avian influenza (bird flu), by exacerbating inflammation and cellular damage. Directly addressing oxidative stress and its consequences is essential

Okomera to Present Automated Desktop Organoid Screening Instrument for Oncology Drug Discovery at SLAS 2025 in San Diego

Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will present their technology in SLAS 2025,in San Diego January 25 to 29, 2025. Okomera will showcase its Automated Desktop Organoid Screening Instrument, a high-throughput platform leveraging proprietary microfluidic chips and AI-powered software to accelerate preclinical drug testing and advance functional precision

Scroll to Top